Search - tctmd.com

Displaying 581 - 600 of 661

Sort: Relevancy | Date

News Daily News

Delayed Postconditioning Ineffective in STEMI Patients Undergoing Primary PCI

Caitlin E. Cox

March 13, 2014

News Daily News

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

March 05, 2014

News Daily News

Moderate/Severe Calcification in ACS Patients Linked to Worse Post-PCI Outcomes

Yael L. Maxwell

February 20, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Daily News

经桡动脉途径PCI何时及如何使ACS及STEMI患者受益

January 01, 2014

News Daily News

Studies Explore How, When Radial PCI Benefits ACS/STEMI Patients

January 01, 2014

News Daily News

Primary PCI Reduces Symptoms vs. Fibrinolysis 5 Years after STEMI

L.A. McKeown

January 01, 2014

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Conference News AHA 2013

STREAM: Pre-hospital Fibrinolysis Strategy as Safe as Primary PCI at 1 Year in STEMI

Yael L. Maxwell

November 18, 2013

News Daily News

SCAI Proposes New Definition for Periprocedural MI

November 01, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

Presentation

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Presenter: Stephen D. Wiviott

August 20, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

July 25, 2013

News Conference News EuroPCR 2013

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Caitlin E. Cox

May 24, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

Advertisement

Delayed Postconditioning Ineffective in STEMI Patients Undergoing Primary PCI

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

Moderate/Severe Calcification in ACS Patients Linked to Worse Post-PCI Outcomes

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

经桡动脉途径PCI何时及如何使ACS及STEMI患者受益

Studies Explore How, When Radial PCI Benefits ACS/STEMI Patients

Primary PCI Reduces Symptoms vs. Fibrinolysis 5 Years after STEMI

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

STREAM: Pre-hospital Fibrinolysis Strategy as Safe as Primary PCI at 1 Year in STEMI

SCAI Proposes New Definition for Periprocedural MI

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content